BI Bets On Expanding Jardiance As Diabetes Drug Sales Soar

 
• By Kevin Grogan
  
Boehringer Ingelheim ARPC
BI board reviews a strong 2018 performance • Source: Boehringer Ingelheim
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip